Prognostic role of preoperative albumin-bilirubin grade on patients with hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis. Issue 7 (July 2020)

• Record Type: Journal Article
• Authors: Geng, Li; Zong, Ruilong; Shi, Yibing; Xu, Kai
• Is Part Of: European journal of gastroenterology & hepatology. Volume 32:Issue 7(2020)
• Publication Date: 2020-07
• Subjects: albumin bilirubin -- hepatocellular carcinoma -- prognosis -- surgery; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; Digestive organs -- Diseases; Liver -- Diseases; Periodicals; 616.33
• DOI: 10.1097/MEG.0000000000001618
• Languages: English
• ISSNs: 0954-691X

Abstract

Abstract : Recent studies have reported albumin-bilirubin (ALBI) grade affected the prognosis of patients with hepatocellular carcinoma (HCC). To more precisely evaluate the relationship among the ALBI grade and the prognosis of patients with HCC after liver resection. We systematically retrieved articles from PubMed, Web of Science, Cochrane Library, and CNKI. The prognostic value of ALBI grade on overall survival (OS) and recurrence-free survival (RFS) of patients with HCC after liver resection was evaluated by pooled hazard ratio (HR) with 95% confidence interval (CI).Through multiple databases search, we enrolled 20 high-quality studies with 11365 patients, regarding the association between the ALBI grade and the prognosis of patients with HCC after liver resection. Our results showed that higher ALBI grade is associated with poored OS (HR, 1.64; 95% CI: 1.51–1.78; P < 0.001; I 2 = 24.9%) and RFS (HR, 1.42; 95% CI: 1.26–1.59; P < 0.001; I 2 = 0). Moreover, subgroup analysis showed the significant correlation between ALBI grade and poor long-term survival was not altered in different geographical areas, sample sizes, follow-up duration, and quality scores. The ALBI grade may be as effective predictive biomarkers for prognosis in patients with HCC after liver resection.